Oral antimicrobial agents in patients with short bowel syndrome: the importance of considering TDM
J Antimicrob Chemother
.
2024 Nov 4;79(11):3048-3049.
doi: 10.1093/jac/dkae321.
Authors
Barbara Deleenheer
1
2
3
,
Matthias Gijsen
1
4
,
Isabel Spriet
1
4
,
Tim Vanuytsel
2
3
5
Affiliations
1
Hospital pharmacy Division, University Hospital Leuven, Leuven, Belgium.
2
Department of Chronic Diseases and Metabolism-Translational Research in Gastrointestinal Disorders (TARGID), KU Leuven, Leuven, Belgium.
3
Leuven Intestinal Failure and Transplantation (LIFT), University Hospital Leuven, Leuven, Belgium.
4
Department of Pharmaceutical and Pharmacological Sciences, KU Leuven, Leuven, Belgium.
5
Division of Gastroenterology and Hepatology, University Hospital Leuven, Leuven, Belgium.
PMID:
39271122
DOI:
10.1093/jac/dkae321
No abstract available
Publication types
Editorial
Comment